García-Diez A - Search Results

1

What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region.

García-Diez A, Foraster CF, Sebastián FV, Tudela LL, Llach XB, Fernández GS. García-Diez A, et al. Dermatology. 2008;216(2):137-51. doi: 10.1159/000111511. Epub 2008 Jan 23. Dermatology. 2008. PMID: 18216476 Free article.

2

Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.

Daudén E, Pedraz J, Alvarez-Ruiz S, García-Río I, Sánchez-Peinado C, Oñate MJ, García-Diez A. Daudén E, et al. Eur J Dermatol. 2010 May-Jun;20(3):321-2. doi: 10.1684/ejd.2010.0899. Epub 2010 Feb 10. Eur J Dermatol. 2010. PMID: 20146966

3

Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.

Fernandez-Peñas P, Jones-Caballero M, Espallardo O, García-Díez A. Fernandez-Peñas P, et al. Br J Dermatol. 2012 Apr;166(4):884-7. doi: 10.1111/j.1365-2133.2012.10806.x. Br J Dermatol. 2012. PMID: 22229951 Clinical Trial.

4

Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.

Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A. Daudén E, et al. Br J Dermatol. 2004 Jan;150(1):132-5. doi: 10.1111/j.1365-2133.2004.05563.x. Br J Dermatol. 2004. PMID: 14746627

5

[Impact of psoriasis on health-related quality of life].

Ferrándiz Foraster C, García-Díez A, Lizán Tudela L, Bermúdez-Rey L, Badia Llach X. Ferrándiz Foraster C, et al. Med Clin (Barc). 2007 Mar 10;128(9):325-9. doi: 10.1157/13099796. Med Clin (Barc). 2007. PMID: 17376358 Spanish.

6

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.

Navarro R, Vilarrasa E, Herranz P, Puig L, Bordas X, Carrascosa JM, Taberner R, Ferrán M, García-Bustinduy M, Romero-Maté A, Pedragosa R, García-Diez A, Daudén E. Navarro R, et al. Br J Dermatol. 2013 Mar;168(3):609-16. doi: 10.1111/bjd.12045. Br J Dermatol. 2013. PMID: 22985451

7

Takayasu's disease with cutaneous involvement.

Pascual-López M, Hernández-Núñez A, Aragüés-Montañés M, Daudén E, Fraga J, García-Díez A. Pascual-López M, et al. Dermatology. 2004;208(1):10-5. doi: 10.1159/000075039. Dermatology. 2004. PMID: 14730230 Review.

8

The relationship between tumour necrosis factor (TNF)-α promoter and IL12B/IL-23R genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study.

Gallo E, Cabaleiro T, Román M, Solano-López G, Abad-Santos F, García-Díez A, Daudén E. Gallo E, et al. Br J Dermatol. 2013 Oct;169(4):819-29. doi: 10.1111/bjd.12425. Br J Dermatol. 2013. PMID: 23662788

9

Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.

Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A. Pedraz J, et al. J Eur Acad Dermatol Venereol. 2006 Jul;20(6):702-6. doi: 10.1111/j.1468-3083.2006.01577.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16836499 Clinical Trial.

10

Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers.

Goiriz R, Daudén E, Pérez-Gala S, Guhl G, García-Díez A. Goiriz R, et al. Clin Exp Dermatol. 2007 Mar;32(2):176-9. doi: 10.1111/j.1365-2230.2006.02315.x. Epub 2006 Dec 14. Clin Exp Dermatol. 2007. PMID: 17176269 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

277 results

Search Page